Finance

Lists
Why is KRSA down 2.21%?
Dive Deeper
KRSA:NASDAQ
Korsana Biosciences, Inc.
$30.48
-2.21%
(-0.69) 1D
Nov 10, 1:49:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRSA...
Open
$31.00
High
$32.30
Low
$30.00
Mkt. cap
1.39B
Avg. vol.
136.48K
Volume
266.16K
52-wk high
$37.25
52-wk low
$21.00
EPS
-$11.76
Beta
1.88
Shares outstanding
45.54M
No. of employees
1
Open
$31.00
High
$32.30
Low
$30.00
Mkt. cap
1.39B
Avg. vol.
136.48K
Volume
266.16K
52-wk high
$37.25
52-wk low
$21.00
EPS
-$11.76
Beta
1.88
Shares outstanding
45.54M
No. of employees
1
News stories
From web sources and news partners
About Korsana Biosciences, Inc.
CEO-
Employees1
Founded2024
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to KRSA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for KRSA in the last 3 months.
Highest
Current $30.48
$70.00 (+129.66%)
Average
$53.00 (+73.88%)
Lowest
$43.00 (+41.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Laura Chico
Wedbush
Buy
Maintained
$44.00
+44.4%
11/06/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$70.00
+129.7%
11/05/2026
Tyler Van Buren
TD Cowen
Buy
Initiated
-
-
09/14/2026
Paul Matteis
Stifel Nicolaus
Buy
Initiated
$43.00
+41.1%
09/14/2026
Michael Yee
UBS
Buy
Initiated
$55.00
+80.4%
09/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2023
Mar 2025
Dec 2025
Mar 2026
Revenue
-
-
1.02M
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
99.00K
-
11.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
44.00K
-
3.28M
Operating expense
-
143.00K
-
14.76M
Total operating expenses
-
143.00K
-
14.76M
Operating income
-
-143.00K
-
-14.76M
Other non operating income
-
-
-
-
EBT including unusual items
-
-73.00K
-
-13.51M
EBT excluding unusual items
-
-73.00K
-
-13.51M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-73.00K
-
-13.51M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
70.00K
-
1.25M
Interest expense
-
-
-
-
Net interest expenses
-
70.00K
-
1.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps